Journal of Ophthalmic & Vision Research (Jan 2016)

Diabetic retinopathy clinical practice guidelines: Customized for Iranian population

  • Zhale Rajavi,
  • Sare Safi,
  • Mohammad Ali Javadi,
  • Mohsen Azarmina,
  • Siamak Moradian,
  • Morteza Entezari,
  • Ramin Nourinia,
  • Hamid Ahmadieh,
  • Armin Shirvani,
  • Saeid Shahraz,
  • Alireza Ramezani,
  • Mohammad Hossein Dehghan,
  • Mohsen Shahsavari,
  • Masoud Soheilian,
  • Homayoun Nikkhah,
  • Hossein Ziaei,
  • Hasan Behboudi,
  • Fereydoun Farrahi,
  • Khalil Ghasemi Falavarjani,
  • Mohammad Mehdi Parvaresh,
  • Hamid Fesharaki,
  • Majid Abrishami,
  • Nasser Shoeibi,
  • Mansour Rahimi,
  • Alireza Javadzadeh,
  • Reza Karkhaneh,
  • Mohammad Riazi-Esfahani,
  • Masoud Reza Manaviat,
  • Alireza Maleki,
  • Bahareh Kheiri,
  • Faegheh Golbafian

DOI
https://doi.org/10.4103/2008-322X.194131
Journal volume & issue
Vol. 11, no. 4
pp. 394 – 414

Abstract

Read online

Purpose: To customize clinical practice guidelines (CPGs) for management of diabetic retinopathy (DR) in the Iranian population. Methods: Three DR CPGs (The Royal College of Ophthalmologists 2013, American Academy of Ophthalmology [Preferred Practice Pattern 2012], and Australian Diabetes Society 2008) were selected from the literature using the AGREE tool. Clinical questions were designed and summarized into four tables by the customization team. The components of the clinical questions along with pertinent recommendations extracted from the above-mentioned CPGs; details of the supporting articles and their levels of evidence; clinical recommendations considering clinical benefits, cost and side effects; and revised recommendations based on customization capability (applicability, acceptability, external validity) were recorded in 4 tables, respectively. Customized recommendations were sent to the faculty members of all universities across the country to score the recommendations from 1 to 9. Results: Agreed recommendations were accepted as the final recommendations while the non-agreed ones were approved after revision. Eventually, 29 customized recommendations under three major categories consisting of screening, diagnosis and treatment of DR were developed along with their sources and levels of evidence. Conclusion: This customized CPGs for management of DR can be used to standardize the referral pathway, diagnosis and treatment of patients with diabetic retinopathy.

Keywords